Brief: Magenta Therapeutics Inc Reports Quarterly Net Loss Per Share Of $0.27

Dianthus Therapeutics

03/11/2022 14:25

Nov 3 (Reuters) - Magenta Therapeutics Inc  MGTA.O :
    * MAGENTA THERAPEUTICS REPORTS THIRD QUARTER FINANCIAL
RESULTS AND
RECENT PROGRAM HIGHLIGHTS
    * QTRLY NET LOSS PER SHARE $0.27
    * Q3 EARNINGS PER SHARE VIEW $-0.30 -- REFINITIV IBES DATA
    * MAINTAINS GUIDANCE THAT CASH RESERVES ARE EXPECTED TO FUND
CURRENT OPERATING PLAN INTO Q2 2024
    * MAGENTA THERAPEUTICS - ANTICIPATES ITS CASH, CASH
EQUIVALENTS
AND MARKETABLE SECURITIES WILL BE SUFFICIENT TO FUND CURRENT
OPERATIONAL PLAN INTO Q2 2024

Source text for Eikon:  ID:nGNX44Lm4c 
Further company coverage:  MGTA.O 
 ((Reuters.Briefs@thomsonreuters.com;;))